D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 48 Citations 13,871 96 World Ranking 11353 National Ranking 487

Overview

What is he best known for?

The fields of study he is best known for:

  • Apoptosis
  • Cancer
  • Genetics

Olivier Micheau spends much of his time researching Cell biology, Apoptosis, Death domain, Fas receptor and FADD. His Cell biology research includes elements of TRADD, Death-inducing signaling complex, Ripoptosome and Caspase 8. His Caspase 8 study integrates concerns from other disciplines, such as RIPK1 and Necroptosis.

The Apoptosis study combines topics in areas such as Tumor necrosis factor alpha, Molecular biology, Cancer research and Receptor. His work in Molecular biology addresses subjects such as DNA fragmentation, which are connected to disciplines such as Caspase. He interconnects Kinase and Receptor complex in the investigation of issues within Signal transducing adaptor protein.

His most cited work include:

  • Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes (1940 citations)
  • Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. (1385 citations)
  • NF-κB Signals Induce the Expression of c-FLIP (710 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Apoptosis, Cell biology, Cancer research, Programmed cell death and Cancer cell. His Apoptosis study combines topics from a wide range of disciplines, such as Tumor necrosis factor alpha, Receptor, Cytotoxic T cell and Molecular biology. His work carried out in the field of Cell biology brings together such families of science as Fas receptor, Death domain, Caspase 8 and Fas ligand.

The Death domain study which covers FADD that intersects with Signal transducing adaptor protein. His Cancer research research is multidisciplinary, relying on both Carcinogenesis, Cancer, Immunology, Immune system and In vivo. His research on Programmed cell death also deals with topics like

  • Flip which is related to area like Ripoptosome,
  • Survivin which connect with XIAP.

He most often published in these fields:

  • Apoptosis (60.53%)
  • Cell biology (51.75%)
  • Cancer research (39.47%)

What were the highlights of his more recent work (between 2015-2021)?

  • Apoptosis (60.53%)
  • Cancer research (39.47%)
  • Receptor (21.05%)

In recent papers he was focusing on the following fields of study:

Olivier Micheau mainly investigates Apoptosis, Cancer research, Receptor, Tumor necrosis factor alpha and Cell biology. His study on FADD is often connected to Magnetic hyperthermia as part of broader study in Apoptosis. The study incorporates disciplines such as Cancer cell, Cancer and Programmed cell death in addition to Cancer research.

His work in the fields of Receptor, such as Agonist and HEK 293 cells, intersects with other areas such as Molecular dynamics and Affinity chromatography. His study in Tumor necrosis factor alpha is interdisciplinary in nature, drawing from both Cell culture, Transferrin, Cytokine, Malignant cells and Immune system. Particularly relevant to Signal transduction is his body of work in Cell biology.

Between 2015 and 2021, his most popular works were:

  • N-glycosylation of mouse TRAIL-R and human TRAIL-R1 enhances TRAIL-induced death (46 citations)
  • TRAIL receptor gene editing unveils TRAIL-R1 as a master player of apoptosis induced by TRAIL and ER stress (45 citations)
  • Regulation of TNF-Related Apoptosis-Inducing Ligand Signaling by Glycosylation. (27 citations)

In his most recent research, the most cited papers focused on:

  • Apoptosis
  • Cancer
  • Genetics

Olivier Micheau mainly focuses on Receptor, Cancer research, Agonist, Cell biology and Apoptosis. His studies in Cancer research integrate themes in fields like Cancer cell, Cancer, Kinase and Programmed cell death. His work on Dependence receptor as part of general Programmed cell death study is frequently linked to Ectodysplasin A receptor, bridging the gap between disciplines.

His research in Agonist tackles topics such as Tumor necrosis factor alpha which are related to areas like Antibody and Cytokine. His research in Cell biology intersects with topics in Trail r1, Glycosylation, FADD and Ligand. His research integrates issues of Molecular biology and Calcium flux in his study of Apoptosis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes

Olivier Micheau;Jürg Tschopp.
Cell (2003)

2751 Citations

Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule.

Nils Holler;Rossana Zaru;Olivier Micheau;Margot Thome.
Nature Immunology (2000)

1820 Citations

NF-κB Signals Induce the Expression of c-FLIP

Olivier Micheau;Susanne Lens;Olivier Gaide;Kostis Alevizopoulos.
Molecular and Cellular Biology (2001)

963 Citations

The Long Form of FLIP Is an Activator of Caspase-8 at the Fas Death-inducing Signaling Complex

Olivier Micheau;Margot Thome;Pascal Schneider;Nils Holler.
Journal of Biological Chemistry (2002)

599 Citations

Recruitment of TNF Receptor 1 to Lipid Rafts Is Essential for TNFα-Mediated NF-κB Activation

Daniel F Legler;Daniel F Legler;Olivier Micheau;Marie-Agnès Doucey;Jürg Tschopp.
Immunity (2003)

521 Citations

Fas Ligand-independent, FADD-mediated Activation of the Fas Death Pathway by Anticancer Drugs

Olivier Micheau;Eric Solary;Arlette Hammann;Marie-Thérèse Dimanche-Boitrel.
Journal of Biological Chemistry (1999)

401 Citations

Sensitization of Cancer Cells Treated With Cytotoxic Drugs to Fas-Mediated Cytotoxicity

Olivier Micheau;Eric Solary;Arlette Hammann;François Martin.
Journal of the National Cancer Institute (1997)

373 Citations

Differential Inhibition of TRAIL-Mediated DR5-DISC Formation by Decoy Receptors 1 and 2

Delphine Mérino;Najoua Lalaoui;Alexandre Morizot;Pascal Schneider.
Molecular and Cellular Biology (2006)

342 Citations

Carma1, a CARD‐containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF‐κB activation1

Olivier Gaide;Fabio Martinon;Olivier Micheau;David Bonnet.
FEBS Letters (2001)

259 Citations

Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells.

Dominique Delmas;Cédric Rébé;Olivier Micheau;Anne Athias.
Oncogene (2004)

233 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Olivier Micheau

Peter Vandenabeele

Peter Vandenabeele

Ghent University

Publications: 91

John Silke

John Silke

Walter and Eliza Hall Institute of Medical Research

Publications: 72

Simone Fulda

Simone Fulda

Goethe University Frankfurt

Publications: 70

Eric Solary

Eric Solary

Institut Gustave Roussy

Publications: 62

Carmen Garrido

Carmen Garrido

Inserm : Institut national de la santé et de la recherche médicale

Publications: 54

Klaus-Michael Debatin

Klaus-Michael Debatin

University of Ulm

Publications: 53

Henning Walczak

Henning Walczak

University College London

Publications: 53

Junying Yuan

Junying Yuan

Harvard University

Publications: 49

James M. Murphy

James M. Murphy

Walter and Eliza Hall Institute of Medical Research

Publications: 46

Harald Wajant

Harald Wajant

University of Würzburg

Publications: 40

Tom Vanden Berghe

Tom Vanden Berghe

Ghent University

Publications: 36

Guido Kroemer

Guido Kroemer

Sorbonne University

Publications: 34

Douglas R. Green

Douglas R. Green

St. Jude Children's Research Hospital

Publications: 33

Peter H. Krammer

Peter H. Krammer

German Cancer Research Center

Publications: 32

Francis Ka-Ming Chan

Francis Ka-Ming Chan

Duke University

Publications: 29

James E. Vince

James E. Vince

Walter and Eliza Hall Institute of Medical Research

Publications: 28

Something went wrong. Please try again later.